CC vs. FMC, OLN, ASH, BCPC, HUN, IOSP, HWKN, NGVT, PRM, and ECVT
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include FMC (FMC), Olin (OLN), Ashland (ASH), Balchem (BCPC), Huntsman (HUN), Innospec (IOSP), Hawkins (HWKN), Ingevity (NGVT), Perimeter Solutions (PRM), and Ecovyst (ECVT). These companies are all part of the "chemicals & allied products" industry.
Chemours (NYSE:CC) and FMC (NYSE:FMC) are both mid-cap basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings, media sentiment and community ranking.
76.3% of Chemours shares are held by institutional investors. Comparatively, 91.9% of FMC shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 0.9% of FMC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, FMC had 2 more articles in the media than Chemours. MarketBeat recorded 7 mentions for FMC and 5 mentions for Chemours. FMC's average media sentiment score of 1.14 beat Chemours' score of 0.55 indicating that FMC is being referred to more favorably in the news media.
Chemours has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500. Comparatively, FMC has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.
Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 4.1%. FMC pays an annual dividend of $2.32 per share and has a dividend yield of 4.1%. Chemours pays out -46.1% of its earnings in the form of a dividend. FMC pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.
FMC has a net margin of 27.65% compared to Chemours' net margin of -5.51%. Chemours' return on equity of 46.67% beat FMC's return on equity.
FMC received 82 more outperform votes than Chemours when rated by MarketBeat users. Likewise, 64.78% of users gave FMC an outperform vote while only 60.95% of users gave Chemours an outperform vote.
Chemours presently has a consensus price target of $30.89, suggesting a potential upside of 27.85%. FMC has a consensus price target of $70.56, suggesting a potential upside of 24.54%. Given Chemours' higher possible upside, research analysts clearly believe Chemours is more favorable than FMC.
FMC has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.
Summary
FMC beats Chemours on 13 of the 20 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
